GR3034629T3 - Fused pyrazine derivative. - Google Patents
Fused pyrazine derivative.Info
- Publication number
- GR3034629T3 GR3034629T3 GR20000402315T GR20000402315T GR3034629T3 GR 3034629 T3 GR3034629 T3 GR 3034629T3 GR 20000402315 T GR20000402315 T GR 20000402315T GR 20000402315 T GR20000402315 T GR 20000402315T GR 3034629 T3 GR3034629 T3 GR 3034629T3
- Authority
- GR
- Greece
- Prior art keywords
- represent
- alkyl
- pyrazine derivative
- nitro
- cycloalkyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP30087990 | 1990-11-06 | ||
JP6959291 | 1991-01-11 | ||
JP13382891 | 1991-03-29 | ||
JP18324891 | 1991-06-27 | ||
PCT/JP1991/001498 WO1992007847A1 (en) | 1990-11-06 | 1991-11-01 | Fused pyrazine derivative |
Publications (1)
Publication Number | Publication Date |
---|---|
GR3034629T3 true GR3034629T3 (en) | 2001-01-31 |
Family
ID=27465151
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GR20000402315T GR3034629T3 (en) | 1990-11-06 | 2000-10-16 | Fused pyrazine derivative. |
Country Status (14)
Country | Link |
---|---|
US (1) | US5283244A (el) |
EP (1) | EP0556393B1 (el) |
JP (1) | JP2550456B2 (el) |
KR (1) | KR0132903B1 (el) |
AT (1) | ATE194985T1 (el) |
AU (1) | AU656154B2 (el) |
CA (1) | CA2095444C (el) |
DE (1) | DE69132340T2 (el) |
DK (1) | DK0556393T3 (el) |
ES (1) | ES2150417T3 (el) |
GR (1) | GR3034629T3 (el) |
HU (2) | HU221425B (el) |
RU (1) | RU2095352C1 (el) |
WO (1) | WO1992007847A1 (el) |
Families Citing this family (44)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK162491D0 (da) * | 1991-09-20 | 1991-09-20 | Novo Nordisk As | Heterocycliske forbindelser, deres fremstilling og farmaceutiske praeparater indeholdende forbindelserne |
US6057304A (en) | 1992-10-26 | 2000-05-02 | Schering Aktiengesellschaft | Quinoxaline-phosphonic acid derivatives |
DE4217952A1 (de) * | 1992-05-30 | 1993-12-02 | Basf Ag | Chinoxalin-2,3(1H,4H)-dione |
WO1994000124A1 (en) * | 1992-06-22 | 1994-01-06 | Eckard Weber | Glycine receptor antagonists and the use thereof |
EP0664807B1 (en) | 1992-10-13 | 1997-09-10 | Warner-Lambert Company | Quinoxalinedione derivatives as eaa antagonists |
PH31122A (en) * | 1993-03-31 | 1998-02-23 | Eisai Co Ltd | Nitrogen-containing fused-heterocycle compounds. |
IL109397A0 (en) * | 1993-04-28 | 1994-07-31 | Schering Ag | Quinoxalinedione derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same |
US5631373A (en) * | 1993-11-05 | 1997-05-20 | State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education, Acting For And On Behalf Of The Oregon Health Sciences University And The University Of Oregon, Eugene Oregon | Alkyl, azido, alkoxy, and fluoro-substituted and fused quinoxalinediones |
DE4340045A1 (de) * | 1993-11-24 | 1995-06-01 | Basf Ag | Neue Chinoxaline und Arzneimittel daraus |
US5620978A (en) * | 1994-01-03 | 1997-04-15 | State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education, Acting For And On Behalf Of The Oregon Health Sciences University And The University Of Oregon, Eugene Oregon | 8-aza, 6-aza and 6,8-diaza-1,4-dihydroquinoxaline-2,3-diones and the use thereof as antagonists for the glycine/NMDA receptor |
AU688459B2 (en) * | 1994-04-08 | 1998-03-12 | Shionogi & Co., Ltd. | Oxopyridinylquinoxaline derivative |
DE4428152A1 (de) * | 1994-06-22 | 1996-01-04 | Basf Ag | Neue Amido-chinoxalindione, ihrer Herstellung und Verwendung |
GB9419318D0 (en) * | 1994-09-24 | 1994-11-09 | Pfizer Ltd | Therapeutic agents |
US6096743A (en) * | 1994-09-27 | 2000-08-01 | Yamanouchi Pharmaceuticals Co., Ltd. | 1,2,3,4-tetrahydroquinoxalinedione derivative |
DE4436852A1 (de) * | 1994-10-14 | 1996-04-18 | Basf Ag | Pyrrolyl-tetrahydrobenzochinoxalindione, ihre Herstellung und Verwendung |
US5801183A (en) * | 1995-01-27 | 1998-09-01 | State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education, Acting For And On Behalf Of The Oregon Health Sciences University And The University Of Oregon | Aza and aza (N-oxy) analogs of glycine/NMDA receptor antagonists |
US6110911A (en) * | 1995-06-07 | 2000-08-29 | Warner-Lambert Company | Cyclic amine derivatives of substituted quinoxaline 2,3-diones as glutamate receptor antagonists |
DE19521058A1 (de) * | 1995-06-09 | 1996-12-12 | Basf Ag | Verfahren zur Herstellung von Aromaten enthaltenden Polyetherpolyolen |
DE19532050A1 (de) * | 1995-08-31 | 1997-03-06 | Basf Ag | Pyrrolyl-tetrahydrochinoxalindione, ihre Herstellung und Verwendung zur Bekämpfung von Krankheiten |
GB9605027D0 (en) * | 1996-03-09 | 1996-05-08 | Pfizer Ltd | Quinoxalinediones |
ZA973884B (en) | 1996-05-23 | 1998-11-06 | Du Pont Merck Pharma | Tetrahydropteridines and pyridylpiperazines for treatment of neurological disorders |
TW448171B (en) * | 1996-06-06 | 2001-08-01 | Yamanouchi Pharma Co Ltd | Imidazole-substituted quinoxalinedione derivatives |
US5824662A (en) * | 1996-09-27 | 1998-10-20 | Guilford Pharmaceuticals Inc. | Treatment of global and focal ischemia using naaladase inhibitors |
US6017903A (en) | 1996-09-27 | 2000-01-25 | Guilford Pharmaceuticals Inc. | Pharmaceutical compositions and methods of treating a glutamate abnormality and effecting a neuronal activity in an animal using NAALADase inhibitors |
DE19624808A1 (de) | 1996-06-21 | 1998-01-02 | Basf Ag | Pyrrolylchinoxalindione, ihre Herstellung und Verwendung |
HUP0001062A3 (en) | 1996-09-27 | 2001-09-28 | Guilford Pharmaceuticals Inc B | Pharmaceutical compositions of phosphinic acid derivatives having naaladase inhibitor acivity |
PT934326E (pt) * | 1996-10-24 | 2006-08-31 | Novartis Ag | Acidos aminoalcanofosfonicos substituidos |
AP982A (en) * | 1997-02-27 | 2001-07-16 | Pfizer | Quinoxalinediones. |
CA2281580C (en) * | 1997-02-27 | 2003-04-22 | Pfizer Inc. | Quinoxalinediones |
TW403740B (en) | 1997-06-10 | 2000-09-01 | Novartis Ag | Novel crystal modifications of the compound 1-(2,6-difluorobenzyl)-1H-1,2,3-triazole-4-carboxamide |
US6015800A (en) * | 1997-09-03 | 2000-01-18 | Warner-Lambert Company | Substituted quinoxaline-2-ones as glutamate receptor antagonists |
AU9651198A (en) | 1997-11-11 | 1999-05-31 | Ono Pharmaceutical Co. Ltd. | Fused pyrazine compounds |
WO2001055110A1 (en) * | 2000-01-24 | 2001-08-02 | Neurosearch A/S | Isatine derivatives with neurotrophic activity |
JP5237798B2 (ja) | 2005-06-23 | 2013-07-17 | アレイ バイオファーマ、インコーポレイテッド | ベンズイミダゾール化合物の調製方法 |
ATE513831T1 (de) * | 2006-04-21 | 2011-07-15 | Pfizer Prod Inc | Pyridinä3,4-büpyrazinone |
US7601716B2 (en) * | 2006-05-01 | 2009-10-13 | Cephalon, Inc. | Pyridopyrazines and derivatives thereof as ALK and c-Met inhibitors |
CN101595100B (zh) | 2007-01-16 | 2014-06-11 | 普渡制药公司 | 作为orl-1配体的杂环取代的哌啶 |
EP2150248A4 (en) | 2007-01-16 | 2011-06-29 | Univ Johns Hopkins | GLUTAMATE RECEPTOR ANTAGONISTS AND METHODS OF USE |
EP3564240B1 (en) * | 2007-08-31 | 2022-04-06 | Purdue Pharma L.P. | Piperidine intermediates |
WO2010053757A1 (en) | 2008-10-29 | 2010-05-14 | Gilead Palo Alto, Inc. | 2 -oxoquinoxalin blockers of the late sodium channel |
WO2010074807A1 (en) | 2008-10-30 | 2010-07-01 | Gilead Palo Alto, Inc. | 3, 4-dihydroquinolin-2 ( 1h ) -one derivatives as sodium channel modulators |
EP2338492A1 (en) | 2009-12-24 | 2011-06-29 | Universidad del Pais Vasco | Methods and compositions for the treatment of alzheimer |
WO2023042888A1 (ja) | 2021-09-15 | 2023-03-23 | 国立大学法人 琉球大学 | 認知機能低下、または過体重もしくは肥満症を処置することに用いるための医薬組成物 |
WO2023042887A1 (ja) | 2021-09-15 | 2023-03-23 | 国立大学法人 琉球大学 | 認知機能低下、または過体重もしくは肥満症を処置することに用いるための医薬組成物 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IE66149B1 (en) * | 1986-09-16 | 1995-12-13 | Novo Nordisk As | Quinoxaline compounds and their preparation and use |
NO179551C (no) * | 1987-11-10 | 1996-10-30 | Novo Nordisk As | Analogifremgangsmåte for fremstilling av terapeutisk virksomme kinoxalinforbindelser |
CA2002864C (en) * | 1988-11-29 | 1999-11-16 | Eddy J. E. Freyne | (1h-azol-1-ylmethyl) substituted quinoline, quinazoline or quinoxaline derivatives |
GB8827822D0 (en) * | 1988-11-29 | 1988-12-29 | Janssen Pharmaceutica Nv | (1h-azol-1-ylmethyl)substituted quinoline derivatives |
DK715888D0 (da) * | 1988-12-22 | 1988-12-22 | Ferrosan As | Quinoxalinforbindelser, deres fremstilling og anvendelse |
-
1991
- 1991-11-01 JP JP3517229A patent/JP2550456B2/ja not_active Expired - Fee Related
- 1991-11-01 CA CA002095444A patent/CA2095444C/en not_active Expired - Fee Related
- 1991-11-01 HU HU9301298A patent/HU221425B/hu unknown
- 1991-11-01 US US08/050,225 patent/US5283244A/en not_active Expired - Lifetime
- 1991-11-01 RU RU93033484/04A patent/RU2095352C1/ru not_active IP Right Cessation
- 1991-11-01 EP EP91918943A patent/EP0556393B1/en not_active Expired - Lifetime
- 1991-11-01 DE DE69132340T patent/DE69132340T2/de not_active Expired - Fee Related
- 1991-11-01 AT AT91918943T patent/ATE194985T1/de not_active IP Right Cessation
- 1991-11-01 WO PCT/JP1991/001498 patent/WO1992007847A1/ja active IP Right Grant
- 1991-11-01 ES ES91918943T patent/ES2150417T3/es not_active Expired - Lifetime
- 1991-11-01 DK DK91918943T patent/DK0556393T3/da active
- 1991-11-01 AU AU87666/91A patent/AU656154B2/en not_active Ceased
-
1993
- 1993-05-04 KR KR1019930701342A patent/KR0132903B1/ko not_active IP Right Cessation
-
1995
- 1995-06-30 HU HU95P/P00644P patent/HU211310A9/hu unknown
-
2000
- 2000-10-16 GR GR20000402315T patent/GR3034629T3/el not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
KR0132903B1 (ko) | 1998-04-17 |
ATE194985T1 (de) | 2000-08-15 |
DE69132340T2 (de) | 2001-02-08 |
HU9301298D0 (en) | 1993-09-28 |
DE69132340D1 (de) | 2000-08-31 |
RU2095352C1 (ru) | 1997-11-10 |
JP2550456B2 (ja) | 1996-11-06 |
EP0556393B1 (en) | 2000-07-26 |
EP0556393A4 (en) | 1994-04-13 |
US5283244A (en) | 1994-02-01 |
CA2095444A1 (en) | 1992-05-07 |
HU221425B (en) | 2002-10-28 |
EP0556393A1 (en) | 1993-08-25 |
DK0556393T3 (da) | 2000-10-16 |
HU211310A9 (en) | 1995-11-28 |
AU8766691A (en) | 1992-05-26 |
CA2095444C (en) | 2001-06-19 |
HUT64324A (en) | 1993-12-28 |
ES2150417T3 (es) | 2000-12-01 |
AU656154B2 (en) | 1995-01-27 |
WO1992007847A1 (en) | 1992-05-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GR3034629T3 (en) | Fused pyrazine derivative. | |
IL97403A0 (en) | 3,5-di-tertiarybutyl-4-hydroxyphenylmethylene derivatives of 2-substituted thiazolidinones,oxazolidinones,and imidazolidinones and pharmaceutical compositions containing them | |
ATE142630T1 (de) | Triazin-derivate und unkrautvertilgungsmittel daraus | |
GB9206244D0 (en) | Cytotoxic compound from a marine sponge | |
DE69330639D1 (de) | Methotrexat-derivate | |
ES2110213T3 (es) | Derivado de n-acilglutamina. | |
GR3021971T3 (en) | Imidazonaphthyridine derivatives | |
HU911119D0 (en) | Izotiazolone containing preparations stabilized with phenoxy-alcanole | |
ATE166875T1 (de) | Ellipticinderivate mit antitumorwirkung | |
DK451389D0 (da) | 2-substituerede 4,5-diaryl-thioimidazoler samt farmaceutisk praeparat indeholdende saadanne forbindelser | |
AU7546794A (en) | Depression remedy | |
DE69326479D1 (de) | Methotrexat-derivate | |
FR2552083B1 (fr) | Derives de (alkynyloxy-3 hydroxy-2-propyl)-4 piperazinyl-1 n-phenyl acetamide, leur preparation et leur application en therapeutique | |
TW360642B (en) | 1,4-Benzoxazine derivatives | |
PL324070A1 (en) | Novel compounds of ellipticin, method of obtaining them and pharmaceutical preparations containing such compounds |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
ML | Lapse due to non-payment of fees |